Q3 2024
|
1 |
426 |
CYCN
|
13F-HR
|
11/14/2024 |
000149315224045808 |
Q2 2024
|
1 |
378 |
CYCN
|
13F-HR
|
8/14/2024 |
000149315224032156 |
Q1 2024
|
1 |
527 |
CYCN
|
13F-HR
|
5/15/2024 |
000149315224019867 |
Q4 2023
|
1 |
550 |
CYCN
|
13F-HR
|
2/14/2024 |
000149315224006681 |
Q3 2023
|
1 |
505 |
CYCN
|
13F-HR
|
11/14/2023 |
000149315223041235 |
Q2 2023
|
1 |
0 |
|
13F-HR
|
8/14/2023 |
000149315223028393 |
Q1 2023
|
1 |
0 |
|
13F-HR
|
5/15/2023 |
000149315223017360 |
Q4 2022
|
1 |
0 |
|
13F-HR
|
2/14/2023 |
000149315223004831 |
Q3 2022
|
1 |
0 |
|
13F-HR
|
11/14/2022 |
000149315222031993 |
Q2 2022
|
1 |
0 |
|
13F-HR
|
8/15/2022 |
000149315222022870 |
Q1 2022
|
1 |
0 |
|
13F-HR
|
5/16/2022 |
000149315222013754 |
Q4 2021
|
1 |
0 |
|
13F-HR
|
2/14/2022 |
000090571822000345 |
Q3 2021
|
1 |
0 |
|
13F-HR
|
11/15/2021 |
000090571821001496 |
Q2 2021
|
1 |
0 |
|
13F-HR
|
8/16/2021 |
000090571821001067 |
Q1 2021
|
1 |
0 |
|
13F-HR
|
5/17/2021 |
000090571821000701 |
Q4 2020
|
1 |
0 |
|
13F-HR
|
2/16/2021 |
000090571821000279 |
Q3 2020
|
1 |
0 |
|
13F-HR
|
11/16/2020 |
000090571820001112 |
Q2 2020
|
1 |
0 |
|
13F-HR
|
8/14/2020 |
000090571820000860 |
Q1 2020
|
1 |
0 |
|
13F-HR
|
5/15/2020 |
000090571820000458 |
Q4 2019
|
2 |
2,321 |
MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
2/14/2020 |
000090571820000216 |
Q3 2019
|
3 |
2,709 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
11/14/2019 |
000090571819000929 |
Q2 2019
|
3 |
4,920 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
8/14/2019 |
000090571819000689 |
Q1 2019
|
3 |
5,056 |
ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
5/15/2019 |
000090571819000455 |
Q4 2018
|
3 |
3,566 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
2/14/2019 |
000090571819000234 |
Q3 2018
|
3 |
7,929 |
ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
11/14/2018 |
000090571818000938 |
Q2 2018
|
3 |
6,888 |
ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
8/14/2018 |
000090571818000754 |
Q1 2018
|
3 |
3,841 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
5/15/2018 |
000090571818000507 |
Q4 2017
|
3 |
3,474 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
2/14/2018 |
000090571818000211 |
Q3 2017
|
4 |
7,824 |
PCOA, ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
11/14/2017 |
000090571817000966 |
Q2 2017
|
4 |
8,449 |
PCOA, ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
8/14/2017 |
000090571817000778 |
Q1 2017
|
3 |
3,477 |
ONTX, MMAC, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
5/15/2017 |
000090571817000566 |
Q4 2016
|
3 |
2,854 |
MMAC, ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
2/14/2017 |
000090571817000231 |
Q3 2016
|
2 |
1,844 |
ONTX, ONCONOVA THERAPEUTICS INC
|
13F-HR
|
11/14/2016 |
000090571816001753 |
Q2 2016
|
1 |
0 |
|
13F-HR
|
8/15/2016 |
000090571816001615 |
Q1 2016
|
1 |
0 |
|
13F-HR
|
5/16/2016 |
000090571816001444 |
Q4 2015
|
1 |
0 |
|
13F-HR
|
2/16/2016 |
000090571816001213 |
Q3 2015
|
1 |
0 |
|
13F-HR
|
11/16/2015 |
000090571815000911 |
Q2 2015
|
1 |
0 |
|
13F-HR
|
8/14/2015 |
000090571815000710 |
Q1 2015
|
1 |
0 |
|
13F-HR
|
5/15/2015 |
000090571815000459 |
Q4 2014
|
1 |
0 |
|
13F-HR
|
2/17/2015 |
000090571815000249 |
Q3 2014
|
1 |
0 |
|
13F-HR
|
11/14/2014 |
000090571814000761 |
Q2 2014
|
1 |
0 |
|
13F-HR
|
8/14/2014 |
000090571814000541 |
Q1 2014
|
1 |
0 |
|
13F-HR
|
5/15/2014 |
000090571814000256 |
Q4 2013
|
1 |
0 |
|
13F-HR
|
2/14/2014 |
000114036114007901 |